Abstract:Abstract Background: Traditionally, it is believed that large tumor suppressor 1 (LATS1) is a negative regulator of oncogene. But the latest research showed that LATS1 has an opposite effect in some tumors. We found that LATS1 has a cancer-promoting effect in BLCA, but the specific mechanism is unknown. Methods: RNAi method was used for the related genetic functional analysis. CCK-8 method and colony formation assay were used to explore the cellular viabilities and proliferation of BLCA cells transfected with LATS1 siRNAs (si-LATS1), in vitro. Flow Cytometry (FCM) was used to analyze the cell cycle and cellular apoptosis of the BLCA cells or the expression of CD68, CD86, CD11b, and CD163 in PMA-treated THP-1 macrophages incubated with conditioned medium (CM) from the si-LATS1 cells or in the THP-1 macrophages cultured directly with BLCA cells. RT-qPCR method was used to detect the mRNA levels of IL-1β, IL-2/4/6/10/18, TNF-α, and IFN-γ in the BLCA cells. Western Blot was performed to detect the expressions of LATS1, Yap1, Bcl-2, Bax, caspase-1/3, GSDMD, TNF-α IL-1β, IL-18, NF-κB, AIM2, NLRC4 and NLRP3 in the BLCA cell lines. For in vivo experiments, a xenograft model was used to investigate the inhibitory effects of LATS1 knockdown on BLCA cells in nude mice.Results: LATS1 knockdown via siRNA inhibited the proliferation of the BLCA cells, neither changing cell cycle distribution nor inducing apoptosis. Via further analysis, we found that the expressions of TNF-α, p-NF-κB/RelA, NLRP3, NLRC4, and AIM2 in si-LATS1 BLCA cells were significantly increased. The activity of caspase-1 and the expressions of IL-1β, IL-18 and GSDMD were obviously increased in the si-LATS1 BLCA cells, which was restored by the addition of NF-κB inhibitor PS341. In the LATS1 over-expression cells (OE-LATS1), the expressions of TNF-α, p-NF-κB/p65, NLRP3, NLRC4 and AIM2 were notably inhibited, and the expressions of IL-1β, IL-18 and GSDMD were significantly decreased. THP-1 macrophages exhibited an M1 phenotype polarization in the presence of si-LATS1 BUC-87 cell supernatant or when cocultured with the BLCA cells transfected with LATS1 siRNA, represented by an increase in the surface expression of CD86. Furthermore, we observed that LATS1 knockdown inhibited the cell proliferation in xenograft model. Conclusion: Our findings showed that LATS1 knockdown via siRNA induces BLCA cell pyrolysis due to the enhanced formation of inflammasomes by activation of TNF-α/NF-κB pathway; and inflammatory factors released by the pyrolytic cells promote M1 polarization of THP-1-derived macrophages in vitro, providing a therapeutic target for BLCA and a brand-new idea for the development of BLCA immunotherapy drugs.

Overexpression of BLCAP Induces S Phase Arrest and Apoptosis Independent of P53 and NF-κB in Human Tongue Carcinoma

Apoptosis-promoting gene (bax) transfer potentiates sensitivity of squamous cell carcinoma to cisplatin in vitro and in vivo.

Blcap Arrests G(1)/S Checkpoint and Induces Apoptosis Through Downregulation of Prb1 in Hela Cells

Functional analysis of bladder cancer-related protein gene: a putative cervical cancer tumor suppressor gene in cervical carcinoma.

Bladder Cancer-Associated Protein Is Suppressed In Human Cervical Tumors

Oncogenic Role of MIR516A in Human Bladder Cancer Was Mediated by Its Attenuating PHLPP2 Expression and BECN1-dependent Autophagy.

CBL0137 Administration Suppresses Human Hepatocellular Carcinoma Cells Proliferation and Induces Apoptosis Associated with Multiple Cell Death Related Proteins.

Overexpression of the Promyelocytic Leukemia Gene Suppresses Growth of Human Bladder Cancer Cells by Inducing G1 Cell Cycle Arrest and Apoptosis

A-to-I RNA Editing of BLCAP Promotes Cell Proliferation by Losing the Inhibitory of Rb1 in Colorectal Cancer

A-to-I RNA editing of BLCAP lost the inhibition to STAT3 activation in cervical cancer.

NCAPG promotes tumorigenesis of bladder cancer through NF-κB signaling pathway

Growth suppression induced by Notch1 activation involves Wnt-beta-catenin down-regulation in human tongue carcinoma cells.

Effects of Inducing Apoptosis and Inhibiting Proliferation of Sirna on Polyadenylate-Binding Protein-Interacting Protein 1 in Tongue Cell Carcinoma.

Aberrant expression of TCTP protein inhibits cell apoptosis by up-regulating Bcl-xL in human pancreatic cancer

Overexpression of PML Induced Apoptosis in Bladder Cancer Cell by Caspase Dependent Pathway.

Inhibitory Effect of Bcl-2 on P53-Mediated Transactivation Following Genotoxic Stress

Inhibition of PP2A by LB100 sensitizes bladder cancer cells to chemotherapy by inducing p21 degradation

Specifically Blocking The Fatty Acid Synthesis To Inhibit The Malignant Phenotype Of Bladder Cancer

Suppression of Bcl-xL Expression by a Novel Tumor-Specific RNA Interference System Inhibits Proliferation and Enhances Radiosensitivity in Prostatic Carcinoma Cells

LATS1 Knockdown with SiRNA Induces Pyroptosis via the Activation of TNF-α/NF-κB Signaling in Bladder Cancer Cells

Ciap1 Promotes Proliferation and Migration and Prevents Apoptosis in Gallbladder Cancer in Vitro